Latest Articles

  • In reply: Angioedema due to the renin inhibitor aliskiren (May 2011)
    Aleksandr Korniyenko, MD and Franz H. Messerli, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 722-723; DOI: https://doi.org/10.3949/ccjm.78c.1104
  • The clinical features of PML
    Joseph R. Berger, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S8-S12; DOI: https://doi.org/10.3949/ccjm.78.s2.03
  • Cervical cancer screening: Less testing, smarter testing
    Cervical cancer screening: Less testing, smarter testing
    Xian Wen Jin, MD, PhD, FACP, Andrea Sikon, MD and Belinda Yen-Lieberman, PhD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 737-747; DOI: https://doi.org/10.3949/ccjm.78a.11033

    The latest guidelines call for less frequent but smarter screening that integrates human papillomavirus testing with the Papanicolaou test.

  • Pharmacovigilance and PML in the oncology setting
    Charles L. Bennett, MD, PhD, MPP
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S13-S17; DOI: https://doi.org/10.3949/ccjm.78.s2.04
  • Nocturia in the elderly: A wake-up call
    Vincent Varilla, MD, Renato V. Samala, MD, Diana Galindo, MD, FACP, AGSF and Jerry Ciocon, MD, FACP, AGSF
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 757-764; DOI: https://doi.org/10.3949/ccjm.78a.11025

    Nocturia is common, but elderly patients infrequently volunteer this complaint, and even when they do, some clinicians may dismiss it.

  • Advances in the management of PML: Focus on natalizumab
    Robert Fox, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S33-S37; DOI: https://doi.org/10.3949/ccjm.78.s2.08
  • Angioedema due to the renin inhibitor aliskiren (May 2011)
    S. Khan
    Cleveland Clinic Journal of Medicine November 2011, 78 (11) 722; DOI: https://doi.org/10.3949/ccjm.78c.1103

    Readers comment on the management of atrial fibrillation (April 2011) and on angioedema due to angiotensin-converting inhibitors and related drugs (May 2011).

  • A rational approach to PML for the clinician
    Leonard Calabrese, DO
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S38-S41; DOI: https://doi.org/10.3949/ccjm.78.s2.09
  • Multiple sclerosis, natalizumab, and PML: Helping patients decide
    Richard A. Rudick, MD
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.78.s2.05
  • HIV-associated PML: Changing epidemiology and clinical approach
    David M. Simpson, MD, FRCP, FAAN
    Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S24-S27; DOI: https://doi.org/10.3949/ccjm.78.s2.06

Pages